Phase I study of cetuximab (CET) in combination with 5-fluorouracil (5-FU), cisplatin (CP), and radiotherapy (RT) in patients with locally advanced squamous cell anal carcinoma (LAAC)

被引：17
|
作者：
Olivatto, L. O. [1 ]
Meton, F. [1 ]
Bezerra, M. [1 ]
Cardoso, A. [1 ]
Araujo, C. M. [1 ]
Castro, L. [1 ]
Moura, R. [1 ]
Pereira, V. [1 ]
Ferreira, C. G. [1 ]
机构：
[1] Inst Nacl Canc, Rio De Janeiro, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4609
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4609
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I-II study of combined 5-fluorouracil and cisplatin chemotherapy and altered fractionation radiotherapy for advanced squamous cell carcinoma of the cervix
    Fishman, A
    Chiu, JK
    Girtanner, RE
    Dennis, W
    Carpenter, LS
    Lu, HH
    Woo, SY
    Kerley, JM
    Kaplan, AL
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (04): : 342 - 347
  • [42] E-TPF (cetuximab, cisplatin, docetaxel, 5-FU) induction chemotherapy in locally advanced squamous cell carcinoma of oral cavity: A phase II study.
    Lu, Hsueh-Ju
    Chang, Mu-Hsin
    Wang, Ling-Wei
    Tai, Shyh-Kuan
    Chen, Ming-Huang
    Chu, Pen-Yuan
    Yang, Muh-Hwa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] Concomitant Chemoradiotherapy with Cisplatin Plus 5-Fluorouracil for Anal Squamous Cell Carcinoma
    El-Hadaad H.A.
    Wahba H.A.
    Roshdy S.
    [J]. Journal of Gastrointestinal Cancer, 2015, 46 (2) : 156 - 160
  • [44] Feasibility of preoperative radiotherapy with weekly oxaliplatin (OXA), 5-fluorouracil (5-FU) continuous infusion in the treatment of locally advanced rectal cancer: Phase I study
    Friso, ML
    Aschele, C
    Pucciarelli, S
    Fabris, G
    Martella, B
    Munegato, M
    Ranzato, R
    Neri, D
    Fasano, C
    Lora, O
    Loreggian, L
    Toppan, P
    Muzzio, PC
    Sotti, G
    [J]. TUMORI, 2001, 87 (04) : S109 - S109
  • [45] A phase I study of cisplatin, methotrexate, levofolinic acid and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck
    Caponigro, F
    Comella, P
    Daponte, A
    Gravina, A
    Carteni, G
    Biglietto, M
    Casaretti, R
    Frasci, G
    Ionna, F
    Mozzillo, N
    Comella, G
    [J]. ONCOLOGY REPORTS, 1997, 4 (06) : 1207 - 1211
  • [46] Concomitant radiochemotherapy with cisplatin (CDDP), 5-fluorouracil (5-FU) and mitomycin C (MMC) in locally advanced oropharyngeal carcinoma: Results of a phase II trial
    Berger, C
    Chapet, S
    Calais, G
    ReynaudBougnoux, A
    Garand, G
    LeFloch, O
    [J]. BULLETIN DU CANCER, 1995, 82 (12) : 1044 - 1051
  • [47] Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R&M SCCHN) (EXTREME).
    Vermorken, J. B.
    Mesia, R.
    Vega-Villegas, M. E.
    Remenar, E.
    Hitt, R.
    Kawecki, A.
    Rottey, S.
    Zabolotnyy, D.
    Erfan, J.
    Amellal, N.
    Antwerpen, U. Z.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 289S - 289S
  • [48] A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma
    Ling, Yang
    Chen, Jia
    Tao, Min
    Chu, Xiaoyuan
    Zhang, Xizhi
    [J]. JOURNAL OF THORACIC DISEASE, 2012, 4 (01) : 58 - 62
  • [49] A phase II study of vinorelbine GIRL), cisplatin (CDDP) and 5-Fluorouracil (FU) in patients (PTS) with locally advanced recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Guillem, V
    Muñoz, MA
    Yaya, R
    Soriano, V
    Climent, MA
    Gaspar, C
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S176 - S176
  • [50] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, H
    Tsukuda, M
    Mochimatu, I
    Ishitoya, J
    Kawai, S
    Mikami, Y
    Matsuda, H
    Tanigaki, Y
    Horiuchi, C
    Ikeda, Y
    Taguchi, T
    Ono, M
    Yoshida, T
    Hirose, S
    Sakuma, Y
    Yamamoto, K
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 348 - 352
12345